FDA
approval
· 2014-04-23
FDA Approved: SYLVANT — Original Application (Recordati Rare Diseases, Inc.)
Summary
The FDA approved Sylvant (siltuximab) under the original application by Recordati Rare Diseases, Inc. for idiopathic multicentric Castleman disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SYLVANT (SILTUXIMAB)